Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model.
dc.contributor.author | Sil, Rajarshi | |
dc.contributor.author | Ray, Doel | |
dc.contributor.author | Chakraborti, Abhay Sankar | |
dc.date.accessioned | 2013-07-30T05:53:41Z | |
dc.date.available | 2013-07-30T05:53:41Z | |
dc.date.issued | 2013-02 | |
dc.description.abstract | This study investigates if glycyrrhizin, a constituent of licorice (Glycyrrhiza glabra) root, is able to treat the complications (insulin resistance, hyperglycemia, dyslipidemia and oxidative stress) of metabolic syndrome. Metabolic syndrome was induced in rats by feeding a fructose-enriched (60%) diet for six weeks, after which single dose of glycyrrhizin (50 mg/kg body weight) was administered intraperitoneally. Different biochemical parameters from blood were estimated during three weeks after treatment. Then the rats were sacrificed to collect skeletal muscle tissue. Glycyrrhizin reduced the enhanced levels of blood glucose, insulin and lipids in metabolic syndrome group. Increased advanced glycation end products of hemoglobin, glycohemoglobin, hemoglobin-mediated iron release and iron-mediated free radical reactions (arachidonic acid and deoxyribose degradation) in metabolic syndrome were inhibited by glycyrrhizin treatment. Reduced activities of enzymatic antioxidants (superoxide dismutase and catalase) and elevated oxidative stress markers (malonaldehyde, fructosamine, hemoglobin carbonyl content and DNA damage) in metabolic syndrome were reversed to almost normal levels by glycyrrhizin. The decreased levels of peroxisome proliferator activated receptor (PPAR) and glucose transporter 4 (GLUT4) proteins in skeletal muscle of metabolic syndrome group were elevated by glycyrrhizin, indicating improved fatty acid oxidation and glucose homeostasis. | en_US |
dc.identifier.citation | Sil Rajarshi, Ray Doel, Chakraborti Abhay Sankar. Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model. Indian Journal of Experimental Biology. 2013 Feb; 51(2): 129-138. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/147576 | |
dc.language.iso | en | en_US |
dc.source.uri | https://nopr.niscair.res.in/handle/123456789/15935 | en_US |
dc.subject | Metabolic syndrome | en_US |
dc.subject | High fructose diet | en_US |
dc.subject | Glycation | en_US |
dc.subject | Insulin resistance | en_US |
dc.subject | Peroxisome proliferator activated receptor | en_US |
dc.subject | Glucose transporter 4 | en_US |
dc.subject.mesh | Animals | |
dc.subject.mesh | Biological Markers --blood | |
dc.subject.mesh | Blood Glucose --drug effects | |
dc.subject.mesh | Blood Glucose --metabolism | |
dc.subject.mesh | Body Weight --drug effects | |
dc.subject.mesh | DNA Damage | |
dc.subject.mesh | Diet | |
dc.subject.mesh | Disease Models, Animal | |
dc.subject.mesh | Dyslipidemias --blood | |
dc.subject.mesh | Dyslipidemias --complications | |
dc.subject.mesh | Dyslipidemias --drug therapy | |
dc.subject.mesh | Free Radical Scavengers --metabolism | |
dc.subject.mesh | Fructose --adverse effects | |
dc.subject.mesh | Glucose Transporter Type 4 --metabolism | |
dc.subject.mesh | Glycyrrhizic Acid --pharmacology | |
dc.subject.mesh | Glycyrrhizic Acid --therapeutic use | |
dc.subject.mesh | Hemoglobins --metabolism | |
dc.subject.mesh | Hyperglycemia --blood | |
dc.subject.mesh | Hyperglycemia --complications | |
dc.subject.mesh | Hyperglycemia --drug therapy | |
dc.subject.mesh | Insulin --blood | |
dc.subject.mesh | Insulin Resistance | |
dc.subject.mesh | Lipids --blood | |
dc.subject.mesh | Lymphocytes --drug effects | |
dc.subject.mesh | Lymphocytes --metabolism | |
dc.subject.mesh | Male | |
dc.subject.mesh | Metabolic Syndrome X --blood | |
dc.subject.mesh | Metabolic Syndrome X --chemically induced | |
dc.subject.mesh | Metabolic Syndrome X --complications | |
dc.subject.mesh | Metabolic Syndrome X --drug therapy | |
dc.subject.mesh | Muscles --drug effects | |
dc.subject.mesh | Muscles --metabolism | |
dc.subject.mesh | Oxidative Stress --drug effects | |
dc.subject.mesh | PPAR gamma --metabolism | |
dc.subject.mesh | Rats | |
dc.subject.mesh | Rats, Wistar | |
dc.subject.mesh | Tissue Extracts | |
dc.title | Glycyrrhizin ameliorates insulin resistance, hyperglycemia, dyslipidemia and oxidative stress in fructose-induced metabolic syndrome-X in rat model. | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijeb2013v51n2p129.pdf
- Size:
- 434.93 KB
- Format:
- Adobe Portable Document Format
- Description:
- Journal article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: